This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Centene Corporation is a well-diversified, multi-national healthcare company that primarily provides a set of services to the government sponsored healthcare programs. The company serves the under-insured and uninsured individuals through member-focused services. It is also engaged in providing education and outreach programs to inform and assist members in accessing quality, appropriate healthcare services. Centene is now a $100-billion plus enterprise catering healthcare services to more than 24 million members across 50 states. The recent acquisition of WellCare Health leveraged the company’s position as the largest Medicaid managed care organization in the country. The combined entity now has 22 million members. In 2019, the company retained its market-leading position nationwide, serving 1.8 million exchange members across 20 states at the year-end.
Ensign Group (ENSG) Grows on Buyouts, High Debt Level a Drag
by Zacks Equity Research
Growing top line, solid inorganic strategies and healthy balance sheet position Ensign Group (ENSG) for long-term growth. However, rising level of debt and expenses hurt the bottom line.
Will Envision Healthcare's Growth Strategies Help the Stock?
by Zacks Equity Research
Envision Healthcare (EVHC) is expected to gain from is a number of long term growth strategies.
Will Community Health Bounce Back in 2018 After a Dismal 2017?
by Zacks Equity Research
Community Health (CYH) suffered in 2017 from weak volumes and high costs. Let's see how this year unfolds.
Acadia Healthcare: 2017 Was No Good, Will 2018 be Better?
by Zacks Equity Research
Acadia Healthcare (ACHC) suffers due to weak U.K. business. Let's see how this year unfolds
4 Reasons Why Envision Healthcare (EVHC) Looks Dull
by Zacks Equity Research
Envision Healthcare continues to suffer from low patient volumes, increased leverage, high operating expense and a weak operating environment.
New Strong Buy Stocks for December 26th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday
Centene, Alaska Air Group, Micron Technology and FedEx highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Centene, Alaska Air Group, Micron Technology and FedEx highlighted as Zacks Bull and Bear of the Day
Bull of the Day: Centene (CNC)
by Kevin Cook
After the company's Investor Day, analysts have raised estimates, price targets, and overall optimism for managed care in 2018
UnitedHealth on A.M.Best's Radar After Buyout Announcement
by Zacks Equity Research
A.M.Best acknowledges UnitedHealth's(UNH) deleveraging strategy and earnings accretion from DaVita Medical Group acquisition.
Community Health (CYH) to Divest 120-Bed Hospital in Florida
by Zacks Equity Research
Community Health (CYH) has been divesting hospitals to lower its debt burden. However, these divestitures have adversely affected the company's top line.
Envision Healthcare Down More Than 50% This Year, Here's Why
by Zacks Equity Research
Envision Healthcare (EVHC) seems to be bogged down by soft patient volumes, increasing expenses and high leverage.
Ensign Group Rides on Inorganic Growth, High Expenses Hurt
by Zacks Equity Research
Although Ensigh Group's (ENSG) revenue growth has been positively impacted by its solid inorganic strategies, it suffers from rising level of expenses that weigh on the margins.
MEDNAX (MD) in Focus: Stock Moves 13.4% Higher
by Zacks Equity Research
MEDNAX (MD) saw its shares rise over 14% on the day after Elliott Management, a big hedge fund, revealed a 7% stake in the company and said that it seeks to enhance shareholders' value.
Zacks.com featured expert Kevin Matras highlights: Dunkin' Brands, Mastercard, Dover and Centene
by Zacks Equity Research
Zacks.com featured expert Kevin Matras highlights: Dunkin' Brands, Mastercard, Dover and Centene
Tenet Healthcare's (THC) Q3 Loss Narrower Than Expected
by Zacks Equity Research
Tenet Healthcare's (THC) third-quarter results were affected by lower revenues and higher expenses.
Community Health (CYH) Incurs Wider-Than-Expected Loss in Q3
by Zacks Equity Research
Community Health's (CYH) third-quarter loss was wider than expected due to huge cat loss.
Envision Healthcare's (EVHC) Q3 Earnings Miss Expectations
by Zacks Equity Research
Envision Healthcare's (EVHC) third-quarter results were adversely impacted by hurricanes Harvey and Irma.
LifePoint Health's (LPNT) Q3 Earnings and Revenues Miss
by Zacks Equity Research
LifePoint Health's (LPNT) third-quarter earnings missed estimates and declined year over year owing to lower revenues.
Strength Seen in Aetna (AET): Stock Soars 11.5%
by Zacks Equity Research
Aetna (AET) saw a big move last session, as its shares jumped nearly 12% on the day, amid huge volumes.
Universal Health (UHS) Q3 Earnings, Revenues Lag Estimates
by Zacks Equity Research
Universal Health's (UHS) third-quarter earnings were driven by solid revenue growth.
Acadia Healthcare (ACHC) Q3 Earnings, Revenues Lag Estimates
by Zacks Equity Research
Acadia Healthcare's (ACHC) third-quarter earnings reflect better performance in its U.S. operations in spite off catastrophe losses playing spoilsport.
Centene's (CNC) Q3 Earnings, Revenues Beat Estimates
by Zacks Equity Research
Centene's (CNC) third-quarter earnings and revenue handily beat estimates.
Why Earnings Season Could Be Great for Centene (CNC)
by Zacks Equity Research
Centene (CNC) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.
Will CNC Q3 Earnings Come in Better Than ESRX on Oct 24?
by Zacks Equity Research
Centene (CNC) is expected to post better results in Q3 compared to Express Scripts (ESRX) on the back of solid revenue growth driven by rising membership.
Can Medicaid Business Drive Centene's (CNC) Q3 Earnings?
by Zacks Equity Research
Centene's (CNC) third-quarter results are expected to be positively impacted by its Medicaid expansion initiatives.